MEVIS MEDICAL SOL.NA O.N.
MEVIS MEDICAL SOL.NA O.N./ DE000A0LBFE4 /
M3V/D
|
6/20/2025 5:36:12 PM
|
Chg.
0.000
|
Volume |
Bid6/20/2025 |
Ask6/20/2025 |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
24.600EUR
|
0.00%
|
109
Turnover: 2,703.200 |
-Bid Size: - |
-Ask Size: - |
45.14 mill.EUR |
- |
- |
Fundamentals
| |
FY 2023 |
Growth (1Y) |
| Per Share |
|
| Earnings per Share: |
0.00 EUR |
- |
| EPS Diluted: |
- EUR |
- |
| Revenues per Share: |
9.53 EUR |
-7.57% |
| Book Value per Share: |
9.79 EUR |
0.00% |
| Cash Flow per Share: |
3.22 EUR |
20.53% |
| Dividend per Share: |
- EUR |
- |
| Total |
in mill. |
|
| Revenues: |
17.34 EUR |
-7.57% |
| Net Income: |
0.00 EUR |
- |
| Operating Cash Flow: |
5.85 EUR |
- |
| Cash and Cash Equivalents: |
7.74 EUR |
- |
Valuation Ratios
| |
Current |
Latest FY* |
| P/E Ratio: |
- |
- |
| P/S Ratio: |
2.60 |
2.62 |
| P/BV ratio: |
2.53 |
2.55 |
| P/CF Ratio: |
7.71 |
7.77 |
| PEG: |
- |
- |
| Earnings Yield: |
- |
0.00% |
| Dividend Yield: |
- |
- |
| Market Capitalization |
|
| Market Capitalization: |
45.14 mill. EUR |
45.5 mill. EUR |
| Free Float Market Cap.: |
- EUR |
- EUR |
| Market Cap. / Employee: |
395,929.8246 EUR |
399,122.8070 EUR |
| Shares Outstanding: |
1.82 mill. |
|
Profitability
| Gross Profit Margin: |
97.43% |
| EBIT Margin: |
0.00% |
| Net Profit Margin: |
0.00% |
| Return on Equity: |
0.00% |
| Return on Assets: |
0.00% |
Financial Strength
| Liquidity I / Cash Ratio: |
- |
| Liquidity II / Quick Ratio: |
- |
| Liquidity III / Current Ratio: |
- |
| Debt / Equity Ratio: |
57.37% |
| Dynam. Debt / Equity Ratio: |
174.70% |
Efficiency
| Employees: |
114 |
| Personal Expenses / Employee: |
- EUR |
| Revenues / Employee: |
152,114.04 EUR |
| Net Income / Employee: |
0.00 EUR |
| Total Assets / Employee: |
246,078.95 EUR |
| * Fiscal Year End: |
9/30/2023 |
